Lab reportFeatured
Retatrutide
Retatrutide 1
Retatrutide 2

Reported purity99.692%–99.808%

Task number#97490

Tested08 JAN 2026

VerificationReport available

View report
Product information

About Retatrutide

Research product

Product overview

Retatrutide is a next-generation investigational peptide supplied by UWA Biotech for laboratory studies involving metabolic regulation, peptide signalling pathways and advanced research applications. This listing is available in wholesale box configurations with multiple vial strengths.

Available formats

  • 10 × 20mg (200mg total)
  • 10 × 30mg (300mg total)
  • MOQ: 10 vials / 1 box
  • Supplier: UWA Biotech

Verification

  • Purity: 99.692%–99.808%
  • Tested: 08 JAN 2026
  • Task number: #97490
  • Unique key: I1X2VVFWT3UM

Supply details

  • Supplier: UWA Biotech
  • Location: United States
  • Formats: 20mg and 30mg options
  • Packaging: Wholesale 10-vial boxes
Research use only

This product is supplied exclusively for laboratory research use. Not for human consumption, medical treatment or clinical application.

Purity99.692%–99.808%

Format20mg / 30mg

MOQ10 vials / 1 box

Ships fromUnited States

Product verification

Laboratory report

Report linked
Reported purity99.692%–99.808%Analytical result shown in the supplied report.
Task number#97490
Tested08 JAN 2026
Report typeJanoshik / COA
Unique IDI1X2VVFWT3UM
Verification documentLaboratory report preview
Full report
Retatrutide verification report
Research use only

This listing is provided for laboratory and research sourcing review. It is not intended for human consumption, medical use or self-administration.

From$175.00
Buy now